Safety and Efficacy of Treatment With Daily Sofosbuvir 400 mg + Ribavirin 200 mg for 24 Weeks in Genotype 1 or 3 HCV-Infected Patients With Severe Renal Impairment

Press/Media: Press / Media

PeriodDec 10 2015

Media coverage

1

Media coverage

  • TitleSafety and Efficacy of Treatment With Daily Sofosbuvir 400 mg + Ribavirin 200 mg for 24 Weeks in Genotype 1 or 3 HCV-Infected Patients With Severe Renal Impairment
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date12/10/15
    PersonsEric J Lawitz